1

Updated 4.24.15

CURRICULUM VITAE
James Russell Sowers, MD, ASCI, FACP, FAHA
Office Address(s) / Department of Internal Medicine
Division of Endocrinology
D109 Diabetes Center - UHC
One Hospital Drive
Columbia, MO 65212
Harry S Truman Memorial Veterans Hospital (Truman VA) Research Service
800 Hospital Drive
Columbia MO 65201
MU Office
Office Telephone:
Cell Telephone:
Fax:
Email: / (573) 884-0769
(573) 823-1002
(573) 884-5530

EDUCATION
1965
1965-1966
1971 / Bachelor of Science in Chemistry - Missouri State and University of Missouri, Columbia, Missouri
University of Missouri Graduate School in Physiology/
Biochemistry
MD - University of Missouri Medical School, Columbia, Missouri
TRAINING
1971-1974
1974-1976 / Internal Medicine Residency, University of Alabama Hospitals and Clinics and St. John's Mercy Medical Center, St. Louis, Missouri
Fellowship in Endocrinology, Department of Medicine, California,
Los Angeles, California and Wadsworth VeteransAdministration
Medical Center
FACULTY APPOINTMENTS
07/1976-07/1978 / Assistant Professor, University of Missouri-Kansas City, School of
Medicine
07/1979-07/1983 / Assistant Chief, Endocrinology - Metabolism, UCLA San Fernando Valley Program
07/1979-07/1983 / Associate Professor of Medicine UCLA
07/1979-07/1983 / Chief, Neuroendocrine Labs, UCLA, San Fernando Valley Program
07/1983-12/1984 / Chief of Endocrinology and Hypertension, McGuire Veterans
Administration Medical Center, Richmond, Virginia
07/1983-12/1984 / Associate Professor of Medicine, Medical College of Virginia
12/1984-11/1999 / Director, Division of Endocrinology, Metabolism and
Hypertension,Wayne State University, Detroit, Michigan
12/1984-11/1999 / Professor of Medicine and Physiology, Wayne State University
School of Medicine
12/1984-11/1999 / Staff Physician, Medical Service VAMC, 4646 John R, Detroit, MI
11/1999-10/2003 / Chief, Endocrinology, Diabetes and Hypertension, SUNY HSC at Brooklyn, New York
11/1999-10/2003 / Staff Physician, Medical Service VAMC, Brooklyn, New York
10/2003-10/2006 / Associate Dean of Clinical Research, School of Medicine, University of Missouri-Columbia, Columbia, Missouri
10/2003-10/2006 / Vice Chair of Research, Dept of Internal Medicine, University of
Missouri-Columbia, Columbia, Missouri
10/2003-10/2006 / Director, Diabetes and Cardiovascular Disease Center, Columbia,
Missouri
10/2003-10/2006 / Professor of Medicine, Physiology & Pharmacology, University of Missouri-Columbia, Columbia, Missouri
10/2003-10/2006 / Staff Physician, Medical Service, Truman VA, Columbia, Missouri
10/2006-03/2007 / Professor of Medicine and Physiology, Director of Diabetes, Hypertension and Metabolism Research, University of Arizona, Tucson, Arizona
04/2007-Present / Thomas W. and Joan F. Burns Missouri Chair in Diabetology
04/2007-Present / Director, Center for Diabetes and Cardiovascular Research, Columbia, Missouri
04/2007-Present / Director, Division of Endocrinology, Diabetes & Metabolism, University of Missouri-Columbia, Columbia, Missouri
04/2007-Present / Staff Physician, Medical Service, Truman VA, Columbia, Missouri
04/2007-Present / Professor of Medicine, Physiology & Pharmacology, University of Missouri-Columbia, Missouri
04/2007-04/2015 / Vice-Chair for Research, Department of Internal Medicine, University of Missouri-Columbia, Columbia, Missouri
MAJOR PROFESSIONAL SOCIETIES
American Society Clinical Investigation
Alpha Omega Alpha, Honor Medical Society
American Physiology Society
Society of Vascular Medicine
American Federation of Clinical Research
Fellow, High Blood Pressure Council
American College of Physicians
Endocrine Society
American Diabetes Association
American Society of Hypertension
American College of Physicians (Fellow)
Southern, Western, and Central Society of Clinical Investigation
International Society of Hypertension
International Society of Hypertension in Blacks
Inter-American Society of Hypertension
LICENSURE & BOARD CERTIFICATION(S)
1974
1977 / Boards in Internal Medicine
Boards in Endocrinology
State Licenses – Arizona, California, Michigan, Missouri, Virginia, New York
HONORS & AWARDS
2012
2011
2010
2010
2008
2008
2006
1989
1986
1970 / Irvine Page-Alva Bradley Lifetime Achievement Award in Hypertension
COSEHC Lifetime Achievement Award
Seale Harris Research Award, Southern Medical Association
Fellow in the American Society of Hypertension
University of Missouri, Medical Alumni Organization Citation of Merit
Alpha Omega Alpha Honor Medical Society Inductee
Midwestern Outstanding Research award of AHA
Detroit Federal Executive Board-Distinguished Scientist
Distinguished Teacher of Department of Medicine, Wayne State University
Lange Medical Award for Scholastic and Research Achievement
SERVICE
Professional Consultation (other patient care)
  • Public presentations as an expert in endocrinology, metabolism and hypertension and vascular medicine
  • No consulting to public agencies, foundations, or professional associations

Journal Editorial Activities
2010-Present
2006-2010
2011-Present / Editor In Chief – CardioRenal Medicine
Journal of Cardiometabolic Syndrome
Associate Editor – Diabetes
Editorial Board Memberships
2006-Present
2006-Present
2004-Present
2002-Present
2002-Present
1996-2004 / Journal of Hypertension
Journal of American Society of Hypertension
Cardiovascular Drug Reviews
American Journal Clinical Hypertension
American Journal Hypertension
Endocrinology, Nutrition, Metabolism and Cardiovascular Diseases, Journal of Clinical Endocrinology & Metabolism
1994-Present
1991-Present
1991-Present / Journal of Human Hypertension
Metabolism
Hypertension
Editorships - Reviewer
New England Journal of Medicine
Hypertension
Journal of Biological Chemistry
Circulation
Circulation Research
American Journal of Physiology
Diabetes
Journal of Clinical Investigation
Journal of Clinical Endocrinology and Metabolism
Endocrinology
American Journal of Medicine
Archives of Internal Medicine
Annals Internal Medicine
Journal American Medical Association
Other Professionally Related Service
  • NIH, VA Merit Board, American Heart National Reviews Committees
  • Department of Veterans Affairs (VA) Joint Biomedical Laboratory Research
and Development and Clinical Science Research and Development Scientific Merit Review Board
  • VCMB (Vascular Cell Molecular Biology) Study Section - NIH
  • Data Monitoring Committee “Combination Angiotensin Receptor Blocker and Angiotensin converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy. Cooperative Studies Program Coordinating Center. VA Connecticut Healthcare System
  • Microcirculation Study Section – NIH

National and International Boards and Committees
  • National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group
  • Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

  • Educational Committee - High Blood Pressure Council
  • Scientific Awards Committee - American Society of Hypertension
  • External Advisory Board – COBRE grant “Hypertension and Cardiorenal Disease Research Center, John Hall, University of Mississippi

State and Local Boards and Committees
2011-Present
2004-Present
2004-Present
2004-Present
2001-2004 / University of Missouri Internal Medicine Research Council, Chair
SOM Administrators Research Council (ARC)
Vice Chair, Truman VA Research and Development (R&D) Committee
Research and Development(R&D) Committee; ACCORD Truman VA
Brooklyn VA Research and Development (R&D) Committee, Chair
COMMITTEES AND STUDY SECTIONS
2010-2015
1989-1993 &
2008-Present
2007-2010
2004-2009
1990-1994 &
2006-Present
2004-2007
2004-2006
2004-2006
1989-1997 & 2001-2006
2999-2005
1991-1994 & 2002-2003
2001-2003
1996-2001
1998
1985-1997
1990-1993
1993
1989-1992
1990-1991
1989-1991
1989-1990 / Charter Member VCMB Study Section – NIH
American Heart Association - Cardiovascular and Renal Study Section
AHA Council for High Blood Pressure
Scientific Oversight Committee – NIH-ACCORD Trial
VA Merit Review Board – Endocrinology
Subcommittee for Animal Studies (SAS), Truman VA Hospital
Admissions Committee, University of Missouri School of Medicine
Chairman, Promotion and Tenure Committee, University of Missouri School of Medicine
NIH Cardiovascular Sections, Ad Hoc Reviewer
American Society of Hypertension Executive Council
NIH GCRC Site Visits
Brooklyn Manhattan VA, R & D, Chair
NIH Experimental Cardiovascular Sciences Study Section Member
ISHIB InternationalConference, Co-Chair
US-Israel Bi-national Science Foundation - Grant Reviewer
Cardiovascular Regulation Research Study Committee, AHA
NIH Consensus on Hypertension and DiabetesNIH Joint National Committee for Blood Pressure (JNC 6 and 7), Chairman
NDC-Nutrition Research Science Advisory Committee Member/
Reviewer
Promotion and Tenure Committee, WSU School of Medicine,Chairman
Wayne State University Executive Committee
Consultant NIH Study Section for (SCOR) Hypertension Grants
TEACHING
Years at Universities
1979-1983
1983-1985
1985-1999
1999-2003
1976-1979 &
2003-Present / UCLA School of Medicine, Los Angles, California
Medical College of Virginia, Richmond, Virginia
Wayne State University, Detroit, Michigan
SUNY Downstate- Brooklyn, New York
University of Missouri, Columbia, Missouri
Doctoral Essays/Theses/Dissertations Directed
1976-1979 & 2003-Present / Paul Standley, Ph.D. Thesis: “Insulin and Hypertension”
Feng Zhang, Ph.D. Thesis: “Sex Hormones and Vascular Calcium Currents”
Ranganath Muniyappa Ph.D. Thesis: “Signal Transduction Mechanisms Mediating IGF-1 Induced Nitric Oxide Release in Endothelial Cells”
Clinical Teaching Activities
  • Attending Faculty – VA Clinic – 3 clinics per week
  • Attending Weekend Consult Faculty – 3 months per year
  • Attending Fellow Clinic – UMC – 6 weeks per year

GRANT SUPPORT
2012-2017 / Principal Investigator: James Sowers, MD / $650,000
Biomedical Laboratory Research and Development (BLR&D) Merit Review
“Interactions of the RAAS and a Western Diet on Insulin Metabolic Actions”
2011-2016 / Principal Investigator: James Sowers, MD / $1,250,000
NHLBI, NIH
“Ang II and Overnutrition and Insulin Resistance in Cardiovascular Tissue”
2009-2014 / Principal Investigator: James Sowers, MD / $1,250,000
NHLBI, NIH
“Ang II and Aldosterone Effects on Insulin Resistance in Cardiovascular Tissue”
2008-2012 / Principal Investigator: James Sowers, MD / $650,000
Biomedical Laboratory Research and Development (BLR&D) Merit Review
“Mechanisms of Angiotensin II and Aldosterone Inhibition of Insulin Metabolic Signaling”
2006-2009 / Principal Investigator: Jamal Ibdah, MD
Co-Principal Investigator: James Sowers, MD / $200,000
Department of Health & Human Services
“Beta-Oxidation and Susceptibility to Fatty Liver Disease”
2005-2010 / Principal Investigator: Virginia Huxley, PhD / $292,000
Co-Principal Investigator: James Sowers, MD
NHLBI, NIH
“Molecular, Cellular and Systems Biomedicine”
2005-2008 / Principal Investigator: Habib Zaghouani, PhD / $175,000
Co-Principal Investigator: James Sowers, MD
NIDDK, NIH
“Immune Tolerance Against Type I Diabetes in Mice”
2004-2009 / Principal Investigator: James Sowers, MD / $135,000
Biomedical Laboratory Research and Development (BLR&D) Merit Review
“Vascular Protein Kinase B/Akt and Rho Signaling: Interactions of IGF-1 and Ang II”
2004-2009 / Principal Investigator: Mark Milanick, PhD / $162,579
Co-Principal Investigator: James Sowers, MD
NIDDK, NIH
“From Clinic to Bench and Back: Clinical Biodetective Training”
2004-2008 / Principal Investigator: James Sowers, MD / $200,000.
NHLBI
“Ang II Opposes INS Mediated Vasorelaxation and GLU Utilization”
2004-2008 / Principal Investigator:Meredith Hay, PhD / $34,000
Co-Principal Investigator: James Sowers, MD
NHLBI, NIH, University of Iowa
“Circumventricular Organs: Gender and Hypertension”
2004-2006 / Principal Investigator: Virginia Huxley, PhD / $266,599
Co-Principal Investigator: James Sowers, MD
NHLBI, NIH
“Cardiovascular and Renal Physiology, Pharmacology and Biochemistry”
2000-2003 / Principal Investigator: James Sowers, MD / $299,997
ADA
“Vascular Interactions of Estradiol and Insulin-Like Growth Factor: Impact of Insulin Resistance and Hypertension”
1990-2004 / Principal Investigator: James Sowers, MD / $982,361
NIH
“Ang II and IGF-1 Interaction in Cardiovascular Tissue”
1999-2002 / Principal Investigator: James Sowers, MD / $450,000
Biomedical Laboratory Research and Development (BLR&D) Merit Review
“Vascular Action of Insulin and IGF-1: PI3-Kinase Related Resistance”
1994-1999 / Principal Investigator: James Sowers, MD / $569,800
Biomedical Laboratory Research and Development (BLR&D) Merit Review
“Actions of Insulin and IGF-I on Vascular Smooth Muscle Cation and Glucose Metabolism”
1994-1999 / Principal Investigator: James Sowers, MD / $159,000
National Heart, Lung, and Blood Institute DVA
“Department of Veteran's Affairs Vanguard Site in the Antihypertensive and Lipid-Lowering Therapy to Prevent Heart Attack Trial (ALLHAT)”
1990-1994 / Principal Investigator: James Sowers, MD / $320,000.
Biomedical Laboratory Research and Development (BLR&D) Merit Review
“Insulin Resistance and Hypertension”
1990-1993 / Principal Investigator: John Waller, MD / $1,460,457
Co-Principal Investigator: James Sowers, MD
NIH
“Health Promotion and Disease Prevention”
1987-1996 / Principal Investigator: James Sowers, MD
NIH
“Insulin Resistance & Altered Cellular Calcium Metabolism in Pregnancy”

PUBLICATIONS

1.Sowers JR, Burkeholder NM, Tumbleson ME, Guthrie RA. Intravenous glucose tolerance test in hormel miniature swine. J Compar Lab Med.1969;3:47.

2.Sowers JR, McCallum RM, Hershman JM, Carson HE. Comparison of metoclopramide with other dynamic tests of prolactin secretion. J Clin Endocrinol Metab. 1976;43:679-681.

3.Sowers JR, Hershman JM, Pekary AE, Nair MG, Baugh CM. Effect of N-3im methyl-thyrotropin releasing hormone on the human pituitary-thyroid axis. J Clin Endocrinol Metab. 1976;43(3):741-748.

4.Sowers JR, Hershman JM, Carlson HE, Pekary AE, Nair MG, Baugh CM. Prolactin response to N-3im methly-thyrotropin releasing hormone in euthyroid subjects. J Clin Endocrinol Metab. 1976;43:749-755.

5.Sowers JR, Hershman JM, Pekary AE, Nair MG, Baugh CM. Dose-response of prolactin and thyrotropin to N-3im methyl-thyrotropin releasing hormone in euthyroid man. J Clin Endocrinol Metab. 1976;43:856-860.

6.McCallum RW, Sowers JR, Hershman JM, Sturdevant RAL. Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab. 1976;43:1148-1152.

7.Sowers JR, Hershman JR, Skowsky WR. Effect of TRH on serum arginine vasopressin in euthyroid and hypothyroid subjects. Hormone Res. 1976;7:232-237.

8.Sowers JR, Carlson HE, Brautbar N, Hershman JM. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man. J Clin Endocrinol Metab. 1977;44(2):237-241.

9.Sowers JR, Hershman JM, Skowsky WR, Carlson HE, Park J. Osmotic control of the release of prolactin and thyrotropin in euthyroid subjects and patients with pituitary tumors. Metabolism. 1977;26(2):187-192.

10.Carlson HE, Sowers JR, Rand RW. Lack of effect of thyroid hormones on the growth hormone response to thyrothropin-releasing hormone in acromegaly. Metabolism. 1977;26(7):801-805.

11.Sowers JR, Raj RP, Hershman JM, Carlson HE, McCallum RW. The effect of stressful diagnostic studies and surgery on anterior pituitary hormone release in man. Acta Endocrinol (KEH). 1977;86(1)25-32.

12.Levine GA, Sowers JR, Hershman JM. The use of intramuscularly administered methyl-TRH to evaluate the pituitary-thyroid axis. Horm Metab Res. 1978;10:(3)233-236.

13.Rubin RT, Poland RE, Sowers JR, Hershman JM. Influence of methyl-TRH induced prolactin increase on serum testosterone levels in normal adult men. J Clin Endocrinol Metab. 1978;46:830-833.

14.Sowers JR, Fayez J, Colantino M, Jonas H. The effect of intra-amniotic prostaglandin F2-alpha on anterior pituitary hormone release during midtrimester abortion. Fertility and Sterility. 1978;30:403-407.

15.Sowers JR, Hershman JM, Carlson HE, Pekary AE. Effect of HCG on thyroid function in euthyroid men. J Clin Endocrinol Metab. 1978;47:898-901.

16.Sowers JR, Colantio M, Fayez J, Jonas H. Pituitary response to LHRH in midtrimester pregnancy. Obstet Gynecol. 1978;52:685-688.

17.Sowers JR, Tempel G, Resch G, Colantio M. Pituitary response to TRH and LHRH in spontaneously hypertensive rats. Proc Soc Exp Biol Med. 1978;159:397-399.

18.Sowers JR, Resch G, Tempel G, Herzog J, Colantio M. Hyperprolactinemia in the spontaneously hypertensive rat. Acta Endocrinol. 1979;90:1-7.

19.Sowers JR, Pekary E, Hershman JM, Kanter M, DiStefano III JJ. Metabolism of exogenous human chorionic gonadotropin in men. J Endocrinol. 1979;80:83-89.

20.McCallum RW, Sowers JR, Carlson HE. Effect of endogenous hyperprolactinemia on lower esophageal sphincter pressure: Its significance in relation to heartburn in pregnancy. Am J Gastroenterol. 1979;71:259-263.

21.Levy CL, Carlson HE, Sowers JR, Goodlett RE, Tourtellotte WW, Hershman JM. Growth hormone and prolactin secretion in Huntington's disease. Life Sci. 1979;24:743-749.

22.Sowers JR, Fayez J. Effect of dexamethasone on gonadotropin responsiveness to luteinizing hormone-releasing hormone and clomiphene in women with secondary amenorrhea. Amer J Obstet Gynecol. 1979;134:325-328.

23.Sowers JR, Rice BF, Blanchard S. Effect of dexamethasone on luteinizing hormone and follicle stimulating hormone responses to LHRH and to clomiphene in the follicular phase of women with normal menstrual cycles. Horm Metab Res. 1979;11(8): 478-480.

24.Sowers JR, Sollars E, Herzog J, Rice B. The effect of neoplasia-induced hypercalcemia on the neuroendocrine axis of the fischer rat. Metabolism. 1980;29(2):146-150.

25.Sowers JR, Walker S, Herzog J. Inhibition of anterior pituitary hormone release by infusion of calcium chloride in the rat. Endocrinology. 1980;106(6):1809-1814.

26.Fayez J, Sowers JR. Evaluation and treatment of patients with prolactin-secreting pituitary tumors. International J Obstet Gynecol. 1980;17:421-427.

27.Sowers JR, Resch G, Walker S, Sollars E. Developmental patterns of the hypothalamic-pituitary axis in the euthyroid and hypothyroid male rat. Neuroendocrinol. 1980;30:257-261.

28.Sowers JR, Barrett JD, Sambhi MP. Effect of L-dopa and bilateral nephrectomy on the aldosterone response to metoclopramide. Life Sci. 1980;27(6):497-501.

29.Sowers JR, Tuck M, Asp N. Dopaminergic modulation of renin activity and aldosterone and prolactin secretion in the spontaneously hypertensive rat. Proc Soc Exp Biol Med. 1980;164(4):598-603.

30.Sowers JR, Tuck ML, Golub MS, Sollars E. Dopaminergic modulation aldosterone secretion is independent of alterations in renin secretion. Endocrinology. 1980;107:937-941.

31.Sowers JR, Sollars E. Effect of rendering male rats hypothyroid at different stages of development adenohypophysial hormone release. Horm Metab Res. 1980;12:524-528.

32.Whitfield L, Sowers JR, Tuck M, Golub MS. Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man. J Clin Endocrinol Metab. 1980;51(4):724-729.

33.Sowers JR, Tuck M, Barrett JD, Sambhi MP, Golub M. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats. Clinical Science. 1980;59(6)101S-103S.

34.Sowers JR, Tuck M, Sowers D. Plasma antithrombin III and thrombin generation time: Correlation with hemoglobin Alc and fasting serum glucose in young diabetic women. Diabetes Care. 1980;3:655-658.

35.Stene M, Panagiotis N, Tuck M, Sowers JR. Plasma norepinephrine levels are influenced by sodium intake, glucocorticoid administration and circadian changes in normal man. J Clin Endocrinol Metab. 1980;51:1340-1345.

36.Sowers JR, Golub M, Tuck M, Sowers DK. Role of prolactin and the renin-angiotensin system in mediating dopaminergic control of aldosterone secretion in the rat. Clin Exp Hyper. 1981;3(1)1-14.

37.Sowers JR, Barrett JD, Sambhi MP. Dopaminergic modulation of renin release. Clin Exp Hypertension. 1981;3(1):15-25.

38.Sowers JR, Tuck M, Asp N, Sollars E. Plasma aldosterone and corticosterone responses to ACTH, angiotensin, potassium and stress in spontaneously hypertensive rats. Endocrinology. 1981;108:1216-1221.

39.Sowers JR, Brickman A, Asp ND, Tuck ML, Jasberg K. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypo-parathyroidism. J Clin Endocrinol Metab. 1981;52:914-918.

40.Tuck ML, Sowers JR, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood plasma renin activity and plasma aldosterone levels in obese patients. New England J Med. 1981;304:930-933.

41.Sowers JR, Sharp B, Levin ER, Golub MS, Eggena P. Metoclopramide, a dopamine antagonist, stimulates aldosterone secretion in rhesus monkeys but not in dogs or rabbits. Life Sci. 1981;29(21):2171-75.

42.Tuck ML, Sowers JR, Fittingoff DB, Mayes DM. Plasma corticosteroid concentrations during spironolactone administration: evidence for adrenal biosynthetic blockade in man. J Clin Endocrinol Metab. 1981;52(6):1057-1061.

43.Sowers JR, Brickman AS, Sowers DK, Berg G. Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockage. J Clin Endocrinol Metab. 1981;52:1078-1084.

44.Sowers JR. Effects of bromocriptine on responses to stress in spontaneously hypertensive rats. Hypertension. 1981;3:544-550.

45.Sowers JR, Sollars E, Nyby M, Jasberg K, Tuck ML. Hypereninimic hypoaldosteronism in association with neoplasis induced hypercalcemia in the fischer rat. Metabolism. 1981;30(10):987-991.

46.Stricker SJ, Sowers DK, Sowers JR, Sirridge M. "Effort Thrombosis" of the subclavian vein associated with oral contraceptives. Annals Emerg Med. 1981;10(11):596-599.

47.Sowers, JR. Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension. J Clin Endocrinol Metab. 1981;53(6):1133-1137.

48.Sowers JR, Golub MS, Eggena PH, Catania RA. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin and prolactin secretion in man. J Clin Endocrinol Metab. 1982;54:121-126.

49.Sowers JR, Catania R, Paris J, Tuck M. Effects of bromocriptine on renin, aldosterone, and prolactin responses to posture and metoclopramide in idiopathic edema: Possible therapeutic approach. J Clin Endocrinol Metab. 1982;54:510-516.

50.Sowers JR, Berg G, Tuck MD, Mayes DM. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab. 1982;54:523-527.

51.Sowers JR, Catania RA, Hershman JM. Evidence for dopaminergic control of circadian variations in thyrotropin secretion. J Clin Endocrinol Metab. 1982;54:673-675.

52.Sowers JR, Berg G, Martin VS, Mayes DM. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone. Endocrinology. 1982;110:1173-1177.

53.Sowers JR, Sharp B, McCallum RW. Effect of domperidone, and extracerebral inhibitor of dopamine receptors on thyrotropin, prolactin, renin, aldosterone and 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab. 1982;54:869-871.

54.Berger ML, Golub ME, Sowers JR, Brickman AS, Nyby M, Troyer H, Rude RK, Singer FR, Horst R, Deftos LJ. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man. Life Sci. 1982;30:1509-1515.

55.Sowers JR, Stern N, Tuck ML, Dornfeld L, Maxwell M. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab. 1982; 54(6):1181-1186.